Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasushi Okoshi

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 10, 2010
[Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange]Mayuko Koshino, Daisuke Kudou, Yasushi Okoshi, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2002
A patient with acquired pure red cell aplasia showing a positive antiglobulin test and the presence of inhibitor against erythroid precursorsYasushi Okoshi, Shigehiko Imagawa, Masato Higuchi, et al.
Scientific Reports|April 14, 2018
Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissueKatsushige Inada, Yasushi Okoshi, Yukiko Cho-Isoda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 20, 2007
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphomaHideharu Muto, Shin Kaneko, Takayuki Machino, et al.
International Journal of Hematology|July 31, 2013
Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension studyShinya Katsutani, Yoshiaki Tomiyama, Akiro Kimura, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|August 8, 2017
A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabineKeiichiro Hattori, Mamiko Sakata-Yanagimoto, Yasushi Okoshi, et al.
International Journal of Hematology|September 14, 2012
Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysisYuhei Kamada, Mamiko Sakata-Yanagimoto, Masashi Sanada, et al.
Case Reports in Hematology|September 8, 2012
Early pathologic findings of bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a proposal from a caseRie Nakamoto-Matsubara, Hidekazu Nishikii, Kenji Yamada, et al.
The Journal of Experimental Medicine|July 25, 2012
Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptorChigusa Nakahashi-Oda, Satoko Tahara-Hanaoka, Masamichi Shoji, et al.
The Journal of Experimental Medicine|July 23, 2003
Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activationKatsumi Yotsumoto, Yasushi Okoshi, Kazuko Shibuya, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 10, 2010
[Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange]Mayuko Koshino, Daisuke Kudou, Yasushi Okoshi, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2002
A patient with acquired pure red cell aplasia showing a positive antiglobulin test and the presence of inhibitor against erythroid precursorsYasushi Okoshi, Shigehiko Imagawa, Masato Higuchi, et al.
Scientific Reports|April 14, 2018
Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissueKatsushige Inada, Yasushi Okoshi, Yukiko Cho-Isoda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 20, 2007
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphomaHideharu Muto, Shin Kaneko, Takayuki Machino, et al.
International Journal of Hematology|July 31, 2013
Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension studyShinya Katsutani, Yoshiaki Tomiyama, Akiro Kimura, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|August 8, 2017
A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabineKeiichiro Hattori, Mamiko Sakata-Yanagimoto, Yasushi Okoshi, et al.
International Journal of Hematology|September 14, 2012
Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysisYuhei Kamada, Mamiko Sakata-Yanagimoto, Masashi Sanada, et al.
Case Reports in Hematology|September 8, 2012
Early pathologic findings of bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a proposal from a caseRie Nakamoto-Matsubara, Hidekazu Nishikii, Kenji Yamada, et al.
The Journal of Experimental Medicine|July 25, 2012
Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptorChigusa Nakahashi-Oda, Satoko Tahara-Hanaoka, Masamichi Shoji, et al.
The Journal of Experimental Medicine|July 23, 2003
Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activationKatsumi Yotsumoto, Yasushi Okoshi, Kazuko Shibuya, et al.
Pageof 4